The global market for Lurasidone Hydrochloride Tablet was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Lurasidone Hydrochloride Tablets is an oral atypical antipsychotic drug, mainly used to treat depressive episodes of schizophrenia and bipolar disorder. Its main ingredient is lurasidone hydrochloride.

North American market for Lurasidone Hydrochloride Tablet is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Lurasidone Hydrochloride Tablet is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Lurasidone Hydrochloride Tablet in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Lurasidone Hydrochloride Tablet include Sumitomo Pharma America, Inc., Dr. Reddy's Laboratories Limited, Teva Takeda Yakuhin Ltd., LTL Pharma Co., Ltd., Mylan Pharmaceuticals, Organon LLC, Santen Pharmaceutical Co.,Ltd., Hengrui Medicine, Teva Pharmaceutical Industries, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Lurasidone Hydrochloride Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lurasidone Hydrochloride Tablet.

The Lurasidone Hydrochloride Tablet market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lurasidone Hydrochloride Tablet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lurasidone Hydrochloride Tablet companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Lurasidone Hydrochloride Tablet Market Report

Report Metric	Details
Report Name	Lurasidone Hydrochloride Tablet Market
Segment by Type	20mg 40mg
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sumitomo Pharma America, Inc., Dr. Reddy's Laboratories Limited, Teva Takeda Yakuhin Ltd., LTL Pharma Co., Ltd., Mylan Pharmaceuticals, Organon LLC, Santen Pharmaceutical Co.,Ltd., Hengrui Medicine, Teva Pharmaceutical Industries
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lurasidone Hydrochloride Tablet company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Lurasidone Hydrochloride Tablet Market report?

Ans: The main players in the Lurasidone Hydrochloride Tablet Market are Sumitomo Pharma America, Inc., Dr. Reddy's Laboratories Limited, Teva Takeda Yakuhin Ltd., LTL Pharma Co., Ltd., Mylan Pharmaceuticals, Organon LLC, Santen Pharmaceutical Co.,Ltd., Hengrui Medicine, Teva Pharmaceutical Industries

What are the Application segmentation covered in the Lurasidone Hydrochloride Tablet Market report?

Ans: The Applications covered in the Lurasidone Hydrochloride Tablet Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Lurasidone Hydrochloride Tablet Market report?

Ans: The Types covered in the Lurasidone Hydrochloride Tablet Market report are 20mg, 40mg

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lurasidone Hydrochloride Tablet Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 20mg

1.2.3 40mg

1.3 Market by Application

1.3.1 Global Lurasidone Hydrochloride Tablet Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Lurasidone Hydrochloride Tablet Market Perspective (2020-2031)

2.2 Global Lurasidone Hydrochloride Tablet Growth Trends by Region

2.2.1 Global Lurasidone Hydrochloride Tablet Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Lurasidone Hydrochloride Tablet Historic Market Size by Region (2020-2025)

2.2.3 Lurasidone Hydrochloride Tablet Forecasted Market Size by Region (2026-2031)

2.3 Lurasidone Hydrochloride Tablet Market Dynamics

2.3.1 Lurasidone Hydrochloride Tablet Industry Trends

2.3.2 Lurasidone Hydrochloride Tablet Market Drivers

2.3.3 Lurasidone Hydrochloride Tablet Market Challenges

2.3.4 Lurasidone Hydrochloride Tablet Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lurasidone Hydrochloride Tablet Players by Revenue

3.1.1 Global Top Lurasidone Hydrochloride Tablet Players by Revenue (2020-2025)

3.1.2 Global Lurasidone Hydrochloride Tablet Revenue Market Share by Players (2020-2025)

3.2 Global Lurasidone Hydrochloride Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Lurasidone Hydrochloride Tablet Revenue

3.4 Global Lurasidone Hydrochloride Tablet Market Concentration Ratio

3.4.1 Global Lurasidone Hydrochloride Tablet Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lurasidone Hydrochloride Tablet Revenue in 2024

3.5 Global Key Players of Lurasidone Hydrochloride Tablet Head office and Area Served

3.6 Global Key Players of Lurasidone Hydrochloride Tablet, Product and Application

3.7 Global Key Players of Lurasidone Hydrochloride Tablet, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Lurasidone Hydrochloride Tablet Breakdown Data by Type

4.1 Global Lurasidone Hydrochloride Tablet Historic Market Size by Type (2020-2025)

4.2 Global Lurasidone Hydrochloride Tablet Forecasted Market Size by Type (2026-2031)

5 Lurasidone Hydrochloride Tablet Breakdown Data by Application

5.1 Global Lurasidone Hydrochloride Tablet Historic Market Size by Application (2020-2025)

5.2 Global Lurasidone Hydrochloride Tablet Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Lurasidone Hydrochloride Tablet Market Size (2020-2031)

6.2 North America Lurasidone Hydrochloride Tablet Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Lurasidone Hydrochloride Tablet Market Size by Country (2020-2025)

6.4 North America Lurasidone Hydrochloride Tablet Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lurasidone Hydrochloride Tablet Market Size (2020-2031)

7.2 Europe Lurasidone Hydrochloride Tablet Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Lurasidone Hydrochloride Tablet Market Size by Country (2020-2025)

7.4 Europe Lurasidone Hydrochloride Tablet Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Lurasidone Hydrochloride Tablet Market Size (2020-2031)

8.2 Asia-Pacific Lurasidone Hydrochloride Tablet Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Lurasidone Hydrochloride Tablet Market Size by Region (2020-2025)

8.4 Asia-Pacific Lurasidone Hydrochloride Tablet Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Lurasidone Hydrochloride Tablet Market Size (2020-2031)

9.2 Latin America Lurasidone Hydrochloride Tablet Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Lurasidone Hydrochloride Tablet Market Size by Country (2020-2025)

9.4 Latin America Lurasidone Hydrochloride Tablet Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lurasidone Hydrochloride Tablet Market Size (2020-2031)

10.2 Middle East & Africa Lurasidone Hydrochloride Tablet Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Lurasidone Hydrochloride Tablet Market Size by Country (2020-2025)

10.4 Middle East & Africa Lurasidone Hydrochloride Tablet Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sumitomo Pharma America, Inc.

11.1.1 Sumitomo Pharma America, Inc. Company Details

11.1.2 Sumitomo Pharma America, Inc. Business Overview

11.1.3 Sumitomo Pharma America, Inc. Lurasidone Hydrochloride Tablet Introduction

11.1.4 Sumitomo Pharma America, Inc. Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025)

11.1.5 Sumitomo Pharma America, Inc. Recent Development

11.2 Dr. Reddy's Laboratories Limited

11.2.1 Dr. Reddy's Laboratories Limited Company Details

11.2.2 Dr. Reddy's Laboratories Limited Business Overview

11.2.3 Dr. Reddy's Laboratories Limited Lurasidone Hydrochloride Tablet Introduction

11.2.4 Dr. Reddy's Laboratories Limited Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025)

11.2.5 Dr. Reddy's Laboratories Limited Recent Development

11.3 Teva Takeda Yakuhin Ltd.

11.3.1 Teva Takeda Yakuhin Ltd. Company Details

11.3.2 Teva Takeda Yakuhin Ltd. Business Overview

11.3.3 Teva Takeda Yakuhin Ltd. Lurasidone Hydrochloride Tablet Introduction

11.3.4 Teva Takeda Yakuhin Ltd. Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025)

11.3.5 Teva Takeda Yakuhin Ltd. Recent Development

11.4 LTL Pharma Co., Ltd.

11.4.1 LTL Pharma Co., Ltd. Company Details

11.4.2 LTL Pharma Co., Ltd. Business Overview

11.4.3 LTL Pharma Co., Ltd. Lurasidone Hydrochloride Tablet Introduction

11.4.4 LTL Pharma Co., Ltd. Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025)

11.4.5 LTL Pharma Co., Ltd. Recent Development

11.5 Mylan Pharmaceuticals

11.5.1 Mylan Pharmaceuticals Company Details

11.5.2 Mylan Pharmaceuticals Business Overview

11.5.3 Mylan Pharmaceuticals Lurasidone Hydrochloride Tablet Introduction

11.5.4 Mylan Pharmaceuticals Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025)

11.5.5 Mylan Pharmaceuticals Recent Development

11.6 Organon LLC

11.6.1 Organon LLC Company Details

11.6.2 Organon LLC Business Overview

11.6.3 Organon LLC Lurasidone Hydrochloride Tablet Introduction

11.6.4 Organon LLC Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025)

11.6.5 Organon LLC Recent Development

11.7 Santen Pharmaceutical Co.,Ltd.

11.7.1 Santen Pharmaceutical Co.,Ltd. Company Details

11.7.2 Santen Pharmaceutical Co.,Ltd. Business Overview

11.7.3 Santen Pharmaceutical Co.,Ltd. Lurasidone Hydrochloride Tablet Introduction

11.7.4 Santen Pharmaceutical Co.,Ltd. Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025)

11.7.5 Santen Pharmaceutical Co.,Ltd. Recent Development

11.8 Hengrui Medicine

11.8.1 Hengrui Medicine Company Details

11.8.2 Hengrui Medicine Business Overview

11.8.3 Hengrui Medicine Lurasidone Hydrochloride Tablet Introduction

11.8.4 Hengrui Medicine Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025)

11.8.5 Hengrui Medicine Recent Development

11.9 Teva Pharmaceutical Industries

11.9.1 Teva Pharmaceutical Industries Company Details

11.9.2 Teva Pharmaceutical Industries Business Overview

11.9.3 Teva Pharmaceutical Industries Lurasidone Hydrochloride Tablet Introduction

11.9.4 Teva Pharmaceutical Industries Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025)

11.9.5 Teva Pharmaceutical Industries Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Dr. Reddy's Laboratories Limited

Teva Takeda Yakuhin Ltd.

LTL Pharma Co., Ltd.

Mylan Pharmaceuticals

Organon

Santen Pharmaceutical Co., Ltd.

Hengrui Medicine

Teva Pharmaceutical Industries

Sumitomo Pharma America, Inc.

List of Tables

Table 1. Global Lurasidone Hydrochloride Tablet Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of 20mg

Table 3. Key Players of 40mg

Table 4. Global Lurasidone Hydrochloride Tablet Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Lurasidone Hydrochloride Tablet Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Lurasidone Hydrochloride Tablet Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Lurasidone Hydrochloride Tablet Market Share by Region (2020-2025)

Table 8. Global Lurasidone Hydrochloride Tablet Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Lurasidone Hydrochloride Tablet Market Share by Region (2026-2031)

Table 10. Lurasidone Hydrochloride Tablet Market Trends

Table 11. Lurasidone Hydrochloride Tablet Market Drivers

Table 12. Lurasidone Hydrochloride Tablet Market Challenges

Table 13. Lurasidone Hydrochloride Tablet Market Restraints

Table 14. Global Lurasidone Hydrochloride Tablet Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Lurasidone Hydrochloride Tablet Market Share by Players (2020-2025)

Table 16. Global Top Lurasidone Hydrochloride Tablet Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lurasidone Hydrochloride Tablet as of 2024)

Table 17. Ranking of Global Top Lurasidone Hydrochloride Tablet Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Lurasidone Hydrochloride Tablet Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Lurasidone Hydrochloride Tablet, Headquarters and Area Served

Table 20. Global Key Players of Lurasidone Hydrochloride Tablet, Product and Application

Table 21. Global Key Players of Lurasidone Hydrochloride Tablet, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Lurasidone Hydrochloride Tablet Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Lurasidone Hydrochloride Tablet Revenue Market Share by Type (2020-2025)

Table 25. Global Lurasidone Hydrochloride Tablet Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Lurasidone Hydrochloride Tablet Revenue Market Share by Type (2026-2031)

Table 27. Global Lurasidone Hydrochloride Tablet Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Lurasidone Hydrochloride Tablet Revenue Market Share by Application (2020-2025)

Table 29. Global Lurasidone Hydrochloride Tablet Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Lurasidone Hydrochloride Tablet Revenue Market Share by Application (2026-2031)

Table 31. North America Lurasidone Hydrochloride Tablet Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Lurasidone Hydrochloride Tablet Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Lurasidone Hydrochloride Tablet Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Lurasidone Hydrochloride Tablet Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Lurasidone Hydrochloride Tablet Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Lurasidone Hydrochloride Tablet Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Lurasidone Hydrochloride Tablet Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Lurasidone Hydrochloride Tablet Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Lurasidone Hydrochloride Tablet Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Lurasidone Hydrochloride Tablet Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Lurasidone Hydrochloride Tablet Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Lurasidone Hydrochloride Tablet Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Lurasidone Hydrochloride Tablet Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Lurasidone Hydrochloride Tablet Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Lurasidone Hydrochloride Tablet Market Size by Country (2026-2031) & (US$ Million)

Table 46. Sumitomo Pharma America, Inc. Company Details

Table 47. Sumitomo Pharma America, Inc. Business Overview

Table 48. Sumitomo Pharma America, Inc. Lurasidone Hydrochloride Tablet Product

Table 49. Sumitomo Pharma America, Inc. Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025) & (US$ Million)

Table 50. Sumitomo Pharma America, Inc. Recent Development

Table 51. Dr. Reddy's Laboratories Limited Company Details

Table 52. Dr. Reddy's Laboratories Limited Business Overview

Table 53. Dr. Reddy's Laboratories Limited Lurasidone Hydrochloride Tablet Product

Table 54. Dr. Reddy's Laboratories Limited Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025) & (US$ Million)

Table 55. Dr. Reddy's Laboratories Limited Recent Development

Table 56. Teva Takeda Yakuhin Ltd. Company Details

Table 57. Teva Takeda Yakuhin Ltd. Business Overview

Table 58. Teva Takeda Yakuhin Ltd. Lurasidone Hydrochloride Tablet Product

Table 59. Teva Takeda Yakuhin Ltd. Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025) & (US$ Million)

Table 60. Teva Takeda Yakuhin Ltd. Recent Development

Table 61. LTL Pharma Co., Ltd. Company Details

Table 62. LTL Pharma Co., Ltd. Business Overview

Table 63. LTL Pharma Co., Ltd. Lurasidone Hydrochloride Tablet Product

Table 64. LTL Pharma Co., Ltd. Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025) & (US$ Million)

Table 65. LTL Pharma Co., Ltd. Recent Development

Table 66. Mylan Pharmaceuticals Company Details

Table 67. Mylan Pharmaceuticals Business Overview

Table 68. Mylan Pharmaceuticals Lurasidone Hydrochloride Tablet Product

Table 69. Mylan Pharmaceuticals Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025) & (US$ Million)

Table 70. Mylan Pharmaceuticals Recent Development

Table 71. Organon LLC Company Details

Table 72. Organon LLC Business Overview

Table 73. Organon LLC Lurasidone Hydrochloride Tablet Product

Table 74. Organon LLC Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025) & (US$ Million)

Table 75. Organon LLC Recent Development

Table 76. Santen Pharmaceutical Co.,Ltd. Company Details

Table 77. Santen Pharmaceutical Co.,Ltd. Business Overview

Table 78. Santen Pharmaceutical Co.,Ltd. Lurasidone Hydrochloride Tablet Product

Table 79. Santen Pharmaceutical Co.,Ltd. Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025) & (US$ Million)

Table 80. Santen Pharmaceutical Co.,Ltd. Recent Development

Table 81. Hengrui Medicine Company Details

Table 82. Hengrui Medicine Business Overview

Table 83. Hengrui Medicine Lurasidone Hydrochloride Tablet Product

Table 84. Hengrui Medicine Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025) & (US$ Million)

Table 85. Hengrui Medicine Recent Development

Table 86. Teva Pharmaceutical Industries Company Details

Table 87. Teva Pharmaceutical Industries Business Overview

Table 88. Teva Pharmaceutical Industries Lurasidone Hydrochloride Tablet Product

Table 89. Teva Pharmaceutical Industries Revenue in Lurasidone Hydrochloride Tablet Business (2020-2025) & (US$ Million)

Table 90. Teva Pharmaceutical Industries Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

Table 94. Authors List of This Report

List of Figures

Figure 1. Lurasidone Hydrochloride Tablet Picture

Figure 2. Global Lurasidone Hydrochloride Tablet Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Lurasidone Hydrochloride Tablet Market Share by Type: 2024 VS 2031

Figure 4. 20mg Features

Figure 5. 40mg Features

Figure 6. Global Lurasidone Hydrochloride Tablet Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Lurasidone Hydrochloride Tablet Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Lurasidone Hydrochloride Tablet Report Years Considered

Figure 12. Global Lurasidone Hydrochloride Tablet Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Lurasidone Hydrochloride Tablet Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Lurasidone Hydrochloride Tablet Market Share by Region: 2024 VS 2031

Figure 15. Global Lurasidone Hydrochloride Tablet Market Share by Players in 2024

Figure 16. Global Top Lurasidone Hydrochloride Tablet Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lurasidone Hydrochloride Tablet as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Lurasidone Hydrochloride Tablet Revenue in 2024

Figure 18. North America Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Lurasidone Hydrochloride Tablet Market Share by Country (2020-2031)

Figure 20. United States Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Lurasidone Hydrochloride Tablet Market Share by Country (2020-2031)

Figure 24. Germany Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Lurasidone Hydrochloride Tablet Market Share by Region (2020-2031)

Figure 32. China Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Lurasidone Hydrochloride Tablet Market Share by Country (2020-2031)

Figure 40. Mexico Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Lurasidone Hydrochloride Tablet Market Share by Country (2020-2031)

Figure 44. Turkey Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Lurasidone Hydrochloride Tablet Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Sumitomo Pharma America, Inc. Revenue Growth Rate in Lurasidone Hydrochloride Tablet Business (2020-2025)

Figure 48. Dr. Reddy's Laboratories Limited Revenue Growth Rate in Lurasidone Hydrochloride Tablet Business (2020-2025)

Figure 49. Teva Takeda Yakuhin Ltd. Revenue Growth Rate in Lurasidone Hydrochloride Tablet Business (2020-2025)

Figure 50. LTL Pharma Co., Ltd. Revenue Growth Rate in Lurasidone Hydrochloride Tablet Business (2020-2025)

Figure 51. Mylan Pharmaceuticals Revenue Growth Rate in Lurasidone Hydrochloride Tablet Business (2020-2025)

Figure 52. Organon LLC Revenue Growth Rate in Lurasidone Hydrochloride Tablet Business (2020-2025)

Figure 53. Santen Pharmaceutical Co.,Ltd. Revenue Growth Rate in Lurasidone Hydrochloride Tablet Business (2020-2025)

Figure 54. Hengrui Medicine Revenue Growth Rate in Lurasidone Hydrochloride Tablet Business (2020-2025)

Figure 55. Teva Pharmaceutical Industries Revenue Growth Rate in Lurasidone Hydrochloride Tablet Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions